These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1542322)

  • 1. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection.
    Sperling RS; Stratton P; O'Sullivan MJ; Boyer P; Watts DH; Lambert JS; Hammill H; Livingston EG; Gloeb DJ; Minkoff H
    N Engl J Med; 1992 Mar; 326(13):857-61. PubMed ID: 1542322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
    Abrams EJ; Matheson PB; Thomas PA; Thea DM; Krasinski K; Lambert G; Shaffer N; Bamji M; Hutson D; Grimm K
    Pediatrics; 1995 Sep; 96(3 Pt 1):451-8. PubMed ID: 7651777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth outcomes following zidovudine therapy in pregnant women.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jun; 43(22):409, 415-6. PubMed ID: 8003111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
    McKinney RE; Maha MA; Connor EM; Feinberg J; Scott GB; Wulfsohn M; McIntosh K; Borkowsky W; Modlin JF; Weintrub P
    N Engl J Med; 1991 Apr; 324(15):1018-25. PubMed ID: 1672443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertical HIV-1 transmission: prophylaxis and paediatric follow-up.
    Carneiro M; Sanchéz A; Maneiro P; Angelosante W; Pérez C; Valleé M
    Placenta; 2001 Apr; 22 Suppl A():S13-8. PubMed ID: 11312622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
    Garcia PM; Kalish LA; Pitt J; Minkoff H; Quinn TC; Burchett SK; Kornegay J; Jackson B; Moye J; Hanson C; Zorrilla C; Lew JF
    N Engl J Med; 1999 Aug; 341(6):394-402. PubMed ID: 10432324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and therapy of human immunodeficiency virus-infected pregnancies in maternal-fetal medicine fellowship training programs.
    Grossman JH; Nies BM; Lopez-Zeno J; Bathgate SL; Parenti DM
    Obstet Gynecol; 1992 Dec; 80(6):985-8. PubMed ID: 1448269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of pregnant women with human immunodeficiency virus (HIV) infection].
    Figueroa Damián R
    Ginecol Obstet Mex; 1995 May; 63():173. PubMed ID: 7789842
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group.
    Blanche S; Rouzioux C; Moscato ML; Veber F; Mayaux MJ; Jacomet C; Tricoire J; Deville A; Vial M; Firtion G
    N Engl J Med; 1989 Jun; 320(25):1643-8. PubMed ID: 2657430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
    N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zidovudine for the prevention of HIV transmission from mother to infant.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Apr; 43(16):285-7. PubMed ID: 8159153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.
    Wade NA; Birkhead GS; Warren BL; Charbonneau TT; French PT; Wang L; Baum JB; Tesoriero JM; Savicki R
    N Engl J Med; 1998 Nov; 339(20):1409-14. PubMed ID: 9811915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
    Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
    Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.
    Lallemant M; Jourdain G; Le Coeur S; Kim S; Koetsawang S; Comeau AM; Phoolcharoen W; Essex M; McIntosh K; Vithayasai V
    N Engl J Med; 2000 Oct; 343(14):982-91. PubMed ID: 11018164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the teratogenic and fetotoxic effects of large doses of chlordiazepoxide used for self-poisoning by 35 pregnant women.
    Gidai J; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):41-51. PubMed ID: 18818180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.